Latest Regulatory News

Tambourah Metals has identified seven promising antimony drill targets at its Speewah Nth project, supported by strong silver and copper anomalies from recent sampling. The company plans up to 1200 metres of reverse circulation drilling pending approvals.

Emu NL has agreed to delay issuing shortfall securities from its entitlement offer until after its extraordinary general meeting on 29 September 2025, following a regulatory undertaking accepted by the Takeovers Panel.

KGL Resources updates on its Jervois Copper Project optimisations and financing progress, welcoming Resource Capital Fund as a new significant shareholder. The company is capitalising on higher metal prices and exploring critical mineral opportunities.

Aldoro Resources has updated the timetable for distributing Sultan Consideration Shares following recent asset divestments, with shareholder approval set for November.

Australian Unity Limited has announced a $120 million equity raising through a pro rata entitlement offer and wholesale placement, underpinning its ongoing transformation and capital management strategy. The company also reported robust FY2025 financial results, highlighting significant revenue growth and improved profitability.

Green Critical Minerals has locked in a $5.2 million underwriting agreement to support the exercise of its expiring options, reinforcing its commercialisation strategy for innovative VHD graphite technology.

My Foodie Box Limited, soon to be Tarrina Resources Limited, is pivoting from meal kits to mineral exploration by acquiring promising gold and base metal projects and raising $5 million to fund exploration.

Indiana Resources Limited has voluntarily suspended trading on the ASX pending a significant announcement related to exploration results and a regulatory price query response.

Flagship Minerals reveals promising expansions at its 1.05 million ounce Pantanillo Gold Project in Chile, with many drill holes ending in mineralisation and potential for higher-grade zones near surface. The company aims to fast-track a JORC-compliant resource estimate and advance project development.

360 Capital Mortgage REIT has announced an estimated ordinary dividend of AUD 0.055 per security for the September quarter, alongside the adoption of the Attribution Managed Investment Trust regime and a Dividend Reinvestment Plan offering.

Race Oncology has secured Investigational New Drug approval from South Korea’s regulatory authority, enabling Phase 1 clinical trials of RC220 in combination with doxorubicin for solid tumour patients across four Korean sites.

EMVision Medical Devices has initiated a unique pre-hospital study in Melbourne to test its First Responder Brain Scanner within one of the world’s few Mobile Stroke Units, aiming to enhance stroke diagnosis and accelerate commercialisation.